Hangzhou – September 10, 2026 -- FastGPT, an open-source AI orchestration platform, has released multiple updated versions -- v4.8.10, v4.9.2 and v4.16.0 -- adding conditional workflow logic and revised self-hosted deployment requirements.

New user selection node enables Confirm/Cancel branching in workflows

The update introduces a user selection node allowing conditional branching via Confirm/Cancel prompts, though the feature is limited to workflow use and incompatible with plugins, tool calls, or Debug mode. Additional workflow changes include automatic edge and center alignment for dragged nodes, local editing history with undo/redo shortcuts, and workflow version renaming. Migrated application call nodes, plugin usage description configuration, and HTTP node support for text/plain mode and timeout settings round out the design updates.

Hyderabad, India – September 10, 2026 -- The global snack bars market is projected to grow from $21.94 billion in 2026 to $32.66 billion by 2031, a compound annual growth rate of 8.28%, according to Mordor Intelligence.

Convenience demand broadens consumption occasions across demographics

Portability is driving snack bars into new use cases beyond traditional snacking, including commuting, school routines, and pre- or post-workout nutrition. Manufacturers are diversifying portfolios across cereal and granola bars, protein and energy bars, and fruit, nut or seed bars to capture more frequent purchases.

San Francisco – September 10, 2026 -- Hagens Berman Sobol Shapiro LLP has filed a securities class action against Regeneron Pharmaceuticals (NASDAQ: REGN) after the failure of a Phase 3 melanoma trial wiped out $11 billion in market capitalization. The suit covers investors who purchased Regeneron shares between August 1, 2025, and May 15, 2026, with a lead plaintiff deadline set for September 14, 2026.

Regeneron's Fianlimab-Libtayo combination failed to hit its primary endpoint

The complaint centers on Regeneron's Phase 3 trial testing Fianlimab combined with Libtayo as a first-line treatment for metastatic or locally advanced melanoma, a therapy management repeatedly called a "potential blockbuster." On May 15, 2026, Regeneron disclosed the trial did not reach statistical significance on its primary endpoint of progression-free survival.

San Francisco – September 10, 2026 -- A securities class action has been filed against PROCEPT BioRobotics Corporation (NASDAQ: PRCT), alleging the company inflated handpiece sales through an undisclosed bulk-discount program that pulled forward demand and masked deteriorating customer inventory levels. Law firm Hagens Berman Sobol Shapiro LLP is representing investors who purchased PROCEPT stock between February 28, 2024 and February 25, 2026, with a lead plaintiff deadline set for September 22, 2026.

San Francisco – September 10, 2026 -- Hagens Berman Sobol Shapiro LLP has filed a securities class action against Cogent Communications Holdings (NASDAQ: CCOI), alleging the company misrepresented its optical wavelength "backlog" as a reliable indicator of revenue growth between February 29, 2024 and May 1, 2026.

Lawsuit targets Cogent's wavelength backlog disclosures as misleading investors

The complaint alleges Cogent's wavelength backlog was largely illusory, with customers unable or unwilling to accept delivery even when the company could provision the wavelengths. Plaintiffs claim this misrepresented actual customer demand and inflated the company's growth narrative.

San Francisco – September 10, 2026 -- Wix.com Ltd. (NASDAQ: WIX) is now the target of a securities class action following a 27% plunge in its share price after the company disclosed Q1 2026 results showing operating expenses had spiked 46% year-over-year. The case, Yappi v. Wix.com Ltd., et al., No. 26-cv-08852, was filed in the U.S. District Court for the Northern District of Illinois and seeks to represent investors who bought Wix securities between February 19, 2025 and May 12, 2026.

SAN FRANCISCO – September 10, 2026 -- Hagens Berman Sobol Shapiro LLP has expanded a securities fraud class action against Pentair plc (NYSE: PNR), extending the class period back to March 11, 2025, from the original start date of April 28, 2026. The lead plaintiff deadline is set for October 2, 2026, giving investors who purchased Pentair stock during the newly expanded window until that date to seek appointment as lead plaintiff.

Lawsuit alleges Pentair concealed severe Pool segment channel destocking

The amended complaint alleges Pentair and top executives made materially false and misleading statements about the company's financial health, channel inventory and internal controls beginning March 11, 2025. Plaintiffs claim Pentair failed to disclose undisclosed channel-loading practices with distributors designed to artificially inflate short-term financial metrics, particularly within its core Pool segment.

San Francisco – September 10, 2026 -- DNOW Inc. (NYSE: DNOW) shares plunged 19% in a single session after the company disclosed that persistent ERP failures at newly acquired MRC Global Inc. had crushed revenues, triggering a securities class action lawsuit filed by Hagens Berman.

The suit centers on proxy materials tied to DNOW's merger with MRC Global, alleging management misrepresented the readiness of MRC's enterprise resource planning system ahead of a shareholder vote.

Shareholders who held stock as of August 5, 2025 form the proposed class

The defined investor class covers DNOW common stockholders as of the August 5, 2025 record date, who were entitled to vote at the company's September 9, 2025 special meeting approving the MRC Global merger. The lead plaintiff deadline is set for October 2, 2026.

Bensalem, Pa. – September 10, 2026 -- The Law Offices of Howard G. Smith has opened a lead plaintiff window until October 2, 2026, for investors who lost money on Pentair plc (NYSE: PNR) shares amid an active securities fraud class action lawsuit.

Complaint alleges Pentair concealed pool channel inventory destocking between March and July 2026

The class action covers investors who purchased Pentair securities between March 11, 2026 and July 14, 2026. The complaint alleges Defendants failed to disclose that significant destocking of inventory was occurring in the Pool channel during that period.

As a result, the lawsuit claims, the company's sales and operating income were adversely affected, rendering the company's positive statements about its business, operations, and prospects materially misleading or lacking a reasonable basis.

Paris – – September 10, 2026 -- The 18th Lyon Contemporary Art Biennale will open two professional accreditation days on September 17-18, 2026, granting industry access to 11 exhibition venues before the show opens to the public on September 19 and runs through December 13, 2026.

Professional accreditation grants early access to 120 artists' work across Lyon

Accreditation is mandatory and nominative for the September 17-18 professional days, with requests accepted through September 16, 2026. Accredited visitors gain access to the exhibition spaces during the trade days, the vernissage at Les Grandes Locos on September 18, and all venues during the first two public days, September 19-20. The professional program includes international meetings, networking sessions and artist dialogues, primarily staged at Les Grandes Locos.